Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial.

Nucci AM, Virtanen SM, Sorkio S, Bärlund S, Cuthbertson D, Uusitalo U, Lawson ML, Salonen M, Berseth CL, Ormisson A, Lehtonen E, Savilahti E, Becker DJ, Dupré J, Krischer JP, Knip M, Åkerblom HK; TRIGR Investigators..

Matern Child Nutr. 2016 Oct 7. doi: 10.1111/mcn.12354. [Epub ahead of print]

PMID:
27714970
2.

Identification of spectral biomarkers for type 1 diabetes mellitus using the combination of chiroptical and vibrational spectroscopy.

Šťovíčková L, Tatarkovič M, Logerová H, Vavřinec J, Setnička V.

Analyst. 2015 Apr 7;140(7):2266-72. doi: 10.1039/c4an01874e.

PMID:
25599101
3.

Recruitment and retention of participants for an international type 1 diabetes prevention trial: a coordinators' perspective.

Franciscus M, Nucci A, Bradley B, Suomalainen H, Greenberg E, Laforte D, Kleemola P, Hyytinen M, Salonen M, Martin MJ, Catte D, Catteau J; TRIGR Investigators..

Clin Trials. 2014 Apr;11(2):150-8. doi: 10.1177/1740774513510070. Epub 2013 Nov 11.

4.

Use of vitamin D supplements during infancy in an international feeding trial.

Lehtonen E, Ormisson A, Nucci A, Cuthbertson D, Sorkio S, Hyytinen M, Alahuhta K, Berseth C, Salonen M, Taback S, Franciscus M, González-Frutos T, Korhonen TE, Lawson ML, Becker DJ, Krischer JP, Knip M, Virtanen SM; TRIGR Investigators..

Public Health Nutr. 2014 Apr;17(4):810-22.

5.

Growth differences between North American and European children at risk for type 1 diabetes.

Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM, Akerblom HK, Knip M; TRIGR Study Group..

Pediatr Diabetes. 2012 Aug;13(5):425-31. doi: 10.1111/j.1399-5448.2011.00840.x. Epub 2012 Jan 17.

6.

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG; Protégé Trial Investigators..

Lancet. 2011 Aug 6;378(9790):487-97. doi: 10.1016/S0140-6736(11)60931-8. Epub 2011 Jun 28.

7.

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.

Walter M, Philotheou A, Bonnici F, Ziegler AG, Jimenez R; NBI-6024 Study Group..

Diabetes Care. 2009 Nov;32(11):2036-40. doi: 10.2337/dc09-0449. Epub 2009 Aug 18.

8.

Multiscale analysis of restoration priorities for marine shoreline planning.

Diefenderfer HL, Sobocinski KL, Thom RM, May CW, Borde AB, Southard SL, Vavrinec J, Sather NK.

Environ Manage. 2009 Oct;44(4):712-31. doi: 10.1007/s00267-009-9298-4. Epub 2009 Jun 4.

PMID:
19495862
9.
10.

Anti-GAD65 reactive peripheral blood mononuclear cells in the pathogenesis of cystic fibrosis related diabetes mellitus.

Stechova K, Kolouskova S, Sumnik Z, Cinek O, Kverka M, Faresjo MK, Chudoba D, Dovolilova E, Pechova M, Vrabelova Z, Böhmova K, Janecek L, Saudek F, Vavrinec J.

Autoimmunity. 2005 Jun;38(4):319-23.

PMID:
16206514
11.

[Childhood diabetes in the Czech Republic: a steady increase in incidence].

Cinek O, Sumník Z, Vavrinec J.

Cas Lek Cesk. 2005;144(4):266-71; discussion 271-2. Czech.

PMID:
15945487
12.

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.

Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C, Kolouskovà S, Linn T, Ludvigsson J, Madàcsy L, Mrozikiewicz AS, Mrozikiewicz PM, Podar T, Vavrinec J, Vialettes B, Visalli N, Yilmaz T, Browne PD; IMDIAB group..

Diabetes Res Clin Pract. 2005 Jun;68(3):258-64. Epub 2004 Nov 21.

PMID:
15936469
13.

[Hormonal suppression and sexual development in children with central precocious puberty in the first treatment cycle 12 weeks after injection of triptoreline 11.25 mg (Diphereline S. R. 11.25 mg): a pilot study].

Snajderová M, Zemková D, Teslík L, Pechová M, Vetesníková-Koubová R, Mlcochová H, Vavrinec J.

Ceska Gynekol. 2005 Mar;70(2):107-13. Czech.

PMID:
15918263
14.

Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes.

Cinek O, Witsø E, Jeansson S, Rasmussen T, Drevinek P, Wetlesen T, Vavrinec J, Grinde B, Rønningen KS.

J Clin Virol. 2006 Jan;35(1):33-40.

PMID:
15916916
15.

[Prediction of type 1 diabetes in the neonates of diabetic mothers or fathers].

Cerná M, Kolousková S, Vavrinec J.

Ceska Gynekol. 2004 Dec;69 Suppl 1:98-101. Czech.

PMID:
15748034
16.

[Type I diabetes mellitus and associated autoimmune diseases in the first-degree relatives of diabetic children: questionnaire based study].

Malcová H, Sumník Z, Drevínek P, Lebl J, Venhácová J, Vavrinec J, Cinek O.

Cas Lek Cesk. 2004;143(9):625-9. Czech.

PMID:
15532904
17.

High prevalence of coeliac disease in siblings of children with type 1 diabetes.

Sumnik Z, Kolouskova S, Malcova H, Vavrinec J, Venhacova J, Lebl J, Cinek O.

Eur J Pediatr. 2005 Jan;164(1):9-12. Epub 2004 Oct 7.

PMID:
15480779
18.

[Association of insulin gene variants with type 1 diabetes mellitus in Czech population].

Cinek O, Drevínek P, Sumník Z, Bendlová B, Vavrinec J.

Cas Lek Cesk. 2004;143(5):318-22. Czech.

PMID:
15305767
19.

Pregnancy in a woman suffering from type 1 diabetes associated with Addison's disease and Hashimoto's thyroiditis (fully developed Autoimmune Polyglandular Syndrome Type 2).

Stechova K, Bartaskova D, Mrstinova M, Cerny M, Snajderova M, Cinek O, Sumnik Z, Vavrinec J.

Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):333-7.

PMID:
15216452
20.

Higher maternal age at delivery, and lower birth orders are associated with increased risk of childhood type 1 diabetes mellitus.

Sumnik Z, Drevinek P, Lanska V, Malcova H, Vavrinec J, Cinek O.

Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):294-7.

PMID:
15216445

Supplemental Content

Loading ...
Support Center